Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Regulus Therapeutics (RGLS)

Regulus Therapeutics (RGLS)
2.07 x 49 2.15 x 13
Post-market by (Cboe BZX)
2.06 +0.12 (+6.19%) 04/17/25 [NASDAQ]
2.07 x 49 2.15 x 13
Post-market 2.10 +0.04 (+1.94%) 19:53 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.92
Day High
2.10
Open 1.92
Previous Close 1.94 1.94
Volume 1,322,800 1,322,800
Avg Vol 2,529,365 2,529,365
Stochastic %K 85.71% 85.71%
Weighted Alpha +18.69 +18.69
5-Day Change +0.34 (+19.77%) +0.34 (+19.77%)
52-Week Range 0.83 - 2.90 0.83 - 2.90
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 136,461
  • Shares Outstanding, K 66,243
  • Annual Sales, $ 0 K
  • Annual Income, $ -46,360 K
  • EBIT $ -50 M
  • EBITDA $ -51 M
  • 60-Month Beta 1.03
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.66

Options Overview Details

View History
  • Implied Volatility 164.89% ( +8.20%)
  • Historical Volatility 102.46%
  • IV Percentile 46%
  • IV Rank 18.19%
  • IV High 790.13% on 12/17/24
  • IV Low 25.89% on 06/14/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 432
  • Volume Avg (30-Day) 494
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 6,223
  • Open Int (30-Day) 5,521

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.33
  • Number of Estimates 2
  • High Estimate -0.22
  • Low Estimate -0.43
  • Prior Year -0.29
  • Growth Rate Est. (year over year) -13.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.27 +62.20%
on 03/26/25
Period Open: 1.37
2.10 -1.90%
on 04/17/25
+0.69 (+50.36%)
since 03/17/25
3-Month
0.83 +148.16%
on 01/29/25
Period Open: 1.24
2.10 -1.90%
on 04/17/25
+0.82 (+66.13%)
since 01/17/25
52-Week
0.83 +148.16%
on 01/29/25
Period Open: 2.34
2.90 -28.97%
on 05/02/24
-0.28 (-11.97%)
since 04/17/24

Most Recent Stories

More News
Regulus: Q4 Earnings Snapshot

Regulus: Q4 Earnings Snapshot

RGLS : 2.06 (+6.19%)
Regulus: Q3 Earnings Snapshot

Regulus: Q3 Earnings Snapshot

RGLS : 2.06 (+6.19%)
Regulus: Q2 Earnings Snapshot

Regulus: Q2 Earnings Snapshot

RGLS : 2.06 (+6.19%)
Regulus: Q1 Earnings Snapshot

Regulus: Q1 Earnings Snapshot

RGLS : 2.06 (+6.19%)
Regulus: Q4 Earnings Snapshot

Regulus: Q4 Earnings Snapshot

RGLS : 2.06 (+6.19%)
Regulus: Q3 Earnings Snapshot

Regulus: Q3 Earnings Snapshot

RGLS : 2.06 (+6.19%)
Regulus Therapeutics Advances to Cohort 3 of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 2.06 (+6.19%)
Regulus Therapeutics Announces Positive Topline Data from the First Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 2.06 (+6.19%)
Regulus Therapeutics Announces Completion of Enrollment in Second Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 2.06 (+6.19%)
Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

RGLS : 2.06 (+6.19%)
Sanderson Farms Stockholders Approve Combination with Cargill and Continental Grain Company

Sanderson Farms, Inc. (NASDAQ: SAFM) (the “Company”) announced that at a special meeting of stockholders held earlier today, its stockholders approved the previously announced agreement for a joint...

SAFM : 204.00 (-2.51%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XOG, VNE, SIC, SAFM, NLOK; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Extraction Oil & Gas, Inc. (NASDAQ:...

XOG : 68.54 (+2.87%)
SAFM : 204.00 (-2.51%)
VNE : 36.95 (+0.19%)
SIC : 14.49 (+0.07%)
NLOK : 21.66 (-2.26%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XOG, SBKK, HBMD, VNE, MDLA, SAFM; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Extraction Oil & Gas, Inc. (NASDAQ:...

HBMD : 23.30 (-2.06%)
XOG : 68.54 (+2.87%)
SAFM : 204.00 (-2.51%)
MDLA : 33.99 (+0.06%)
SBKK : 18.5800 (+1.03%)
VNE : 36.95 (+0.19%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CSOD, IKNX, MDLA, SAFM; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / October 4, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cornerstone OnDemand, Inc. (NASDAQ:CSOD) concerning...

SAFM : 204.00 (-2.51%)
MDLA : 33.99 (+0.06%)
CSOD : 57.49 (+0.02%)
IKNX : 33.90 (-0.29%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CSOD, IKNX, MDLA, SAFM; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / October 4, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cornerstone OnDemand, Inc. (NASDAQ:CSOD) concerning...

SAFM : 204.00 (-2.51%)
MDLA : 33.99 (+0.06%)
CSOD : 57.49 (+0.02%)
IKNX : 33.90 (-0.29%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates GWB, SAFM, LMRK, IDEX; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / September 24, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Great Western Bancorp, Inc. (NYSE:GWB) concerning...

GWB : 30.88 (-1.59%)
SAFM : 204.00 (-2.51%)
LMRK : 16.49 (+0.30%)
IDEX : 0.2700 (+35.00%)
Sanderson Farms, Inc. Announces Quarterly Dividend

Sanderson Farms, Inc. (NASDAQ: SAFM) today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.44 (forty-four cents) per share payable October 19, 2021, to stockholders...

SAFM : 204.00 (-2.51%)
Moore Kuehn Encourages MSON, LMRK, SAFM, and SVBI Investors to Contact Law Firm

NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning...

MSON : 26.54 (+4.74%)
SAFM : 204.00 (-2.51%)
LMRK : 16.49 (+0.30%)
SVBI : 13.63 (+5.66%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XENT, INOV, SAFM, HOMB; Shareholders are Encouraged to Contact the Firm

NEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SAFM : 204.00 (-2.51%)
XENT : 28.24 (unch)
HOMB : 26.46 (+1.85%)
INOV : 30.03 (+0.67%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of LONE, MGP, SAFM, and GNOG Mergers

WILMINGTON, Del., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating:

SAFM : 204.00 (-2.51%)
MGP : 41.64 (+3.12%)
LONE : 16.0000 (+6.24%)
GNOG : 5.78 (+5.09%)
Sanderson Farms Stockholders Approve Combination with Cargill and Continental Grain Company

Sanderson Farms, Inc. (NASDAQ: SAFM) (the “Company”) announced that at a special meeting of stockholders held earlier today, its stockholders approved the previously announced agreement for a joint...

SAFM : 204.00 (-2.51%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XOG, VNE, SIC, SAFM, NLOK; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Extraction Oil & Gas, Inc. (NASDAQ:...

XOG : 68.54 (+2.87%)
SAFM : 204.00 (-2.51%)
VNE : 36.95 (+0.19%)
SIC : 14.49 (+0.07%)
NLOK : 21.66 (-2.26%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XOG, SBKK, HBMD, VNE, MDLA, SAFM; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Extraction Oil & Gas, Inc. (NASDAQ:...

HBMD : 23.30 (-2.06%)
XOG : 68.54 (+2.87%)
SAFM : 204.00 (-2.51%)
MDLA : 33.99 (+0.06%)
SBKK : 18.5800 (+1.03%)
VNE : 36.95 (+0.19%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CSOD, IKNX, MDLA, SAFM; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / October 4, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cornerstone OnDemand, Inc. (NASDAQ:CSOD) concerning...

SAFM : 204.00 (-2.51%)
MDLA : 33.99 (+0.06%)
CSOD : 57.49 (+0.02%)
IKNX : 33.90 (-0.29%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CSOD, IKNX, MDLA, SAFM; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / October 4, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cornerstone OnDemand, Inc. (NASDAQ:CSOD) concerning...

SAFM : 204.00 (-2.51%)
MDLA : 33.99 (+0.06%)
CSOD : 57.49 (+0.02%)
IKNX : 33.90 (-0.29%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates GWB, SAFM, LMRK, IDEX; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / September 24, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Great Western Bancorp, Inc. (NYSE:GWB) concerning...

GWB : 30.88 (-1.59%)
SAFM : 204.00 (-2.51%)
LMRK : 16.49 (+0.30%)
IDEX : 0.2700 (+35.00%)
Sanderson Farms, Inc. Announces Quarterly Dividend

Sanderson Farms, Inc. (NASDAQ: SAFM) today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.44 (forty-four cents) per share payable October 19, 2021, to stockholders...

SAFM : 204.00 (-2.51%)
Moore Kuehn Encourages MSON, LMRK, SAFM, and SVBI Investors to Contact Law Firm

NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning...

MSON : 26.54 (+4.74%)
SAFM : 204.00 (-2.51%)
LMRK : 16.49 (+0.30%)
SVBI : 13.63 (+5.66%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XENT, INOV, SAFM, HOMB; Shareholders are Encouraged to Contact the Firm

NEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SAFM : 204.00 (-2.51%)
XENT : 28.24 (unch)
HOMB : 26.46 (+1.85%)
INOV : 30.03 (+0.67%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of LONE, MGP, SAFM, and GNOG Mergers

WILMINGTON, Del., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating:

SAFM : 204.00 (-2.51%)
MGP : 41.64 (+3.12%)
LONE : 16.0000 (+6.24%)
GNOG : 5.78 (+5.09%)

Business Summary

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and...

See More

Key Turning Points

3rd Resistance Point 2.31
2nd Resistance Point 2.21
1st Resistance Point 2.13
Last Price 2.06
1st Support Level 1.95
2nd Support Level 1.85
3rd Support Level 1.77

See More

52-Week High 2.90
Fibonacci 61.8% 2.11
Last Price 2.06
Fibonacci 50% 1.87
Fibonacci 38.2% 1.62
52-Week Low 0.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.